[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"trunk\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:trunk":29},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,46,72],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100452168","phase-2-preoperative-imrt-with-anlotinib-and-penpulimab-for-localized-sarcoma-spare-01-100452168",false,"NCT05167994","Preoperative IMRT With Anlotinib and Penpulimab for Localized Sarcoma （SPARE-01）","Preoperative Intensity-Modulated Radiotherapy (IMRT) Combined With Concurrent Anlotinib Hydrochloride and Penpulimab for Localized Extremity or Trunk Sarcoma","SPARE-01","Inclusion Criteria:\n\n* Age older than 18-yo\n* Histology proven soft tissue sarcoma of truncal or extremity, deemed appropriate for preoperative radiotherapy and conservative surgery by multidisciplinary discussion.\n* ECOG 0-3\n* Histology reviewed by reference pathologist\n* Lesion can be assessed\n* Can tolerate radiotherapy and Anlotinib\n* Agree contraception.\n* Informed consent: All patients must sign a document of informed consent indicating their understanding of the investigational nature and risks of the study before any protocol related studies are performed\n\nExclusion Criteria:\n\n* No gross tumor post-resection in other center.\n* Contraindications to Anlotinib, including allergic to Anlotinb, active bleeding, ulcer, enteric perforation, enteric obstruction, uncontrolled hypertension, Grade 3 to 4 cardiac insufficiency (per NYHA criteria), and severe hepatic or renal insufficiency (Grade 4), etc.\n* Dermatofibrosarcoma protuberans(DFSP), Desmoids, etc.\n* Benign histology\n* Secondary cancer within 5 years (except cervical carcinoma in situ or early-stage skin basal cell carcinoma)\n* STS can be cured by extensive operation alone.\n* Previous irradiation to the same area\n* Radiological evidence of distant metastases\n* Other contraindications, can't tolerate operation or other treatment needed in this study.\n* Neoadjuvant chemotherapy given or planned.","ALL","18 Years",{"count":20,"type":21},30,"ESTIMATED","INTERVENTIONAL",[24],"PHASE2","To investigate the safety and efficacy of preoperative IMRT and concurrent Anlotinib Hydrochloride for primary truncal or extremity soft tissue sarcoma; To investigate the Quality of life and extremity function post-combination treatment; To study the mechanism of radio-sensitizing effects of Anlotinib Hydrochloride and Penpulimab for primary truncal or extremity soft tissue sarcoma; To assess the relationship between the MRI imaging, pathological findings and local control.",[27,28,29,30,31,32],"Sarcoma,Soft Tissue","Extremity","Trunk","Anlotinib","Intensity-modulated Radiotherapy","Major Wound Complications","RECRUITING","2026-06-03",{"date":36,"type":37},"2026-06-04","ACTUAL",{"date":39,"type":37},"2020-05-01",{"date":41,"type":21},"2027-12-31",{"name":43,"class":44},"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":53,"targetDuration":4,"studyType":55,"phases":4,"briefSummary":56,"conditions":57,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":66,"completionDateStruct":68,"leadSponsor":70,"locationsCount":45},"100588798","the-effect-of-upper-extremity-motor-function-trunk-control-and-motor-imagery-ability-on-turkish-language-skills-in-individuals-with-stroke-100588798","NCT06946082","The Effect of Upper Extremity Motor Function, Trunk Control and Motor Imagery Ability on Turkish Language Skills in Individuals With Stroke","It is to Examine the Relationship Between Upper Extremity Motor Function, Trunk Control, Motor Imagery.","Inclusion Criteria:\n\n* 18 years of age or older\n* Stroke onset more than 1 week\n* Not having practiced imagery before\n* Being a native speaker of Turkish\n* Standardized Mini Mental Test (SMMT) Score of 24 and above\n* History of cerebrovascular events\n* Not having any neurological disorder other than stroke\n* The ability to grasp and hold a 2.5 cm cube\n\nExclusion Criteria:\n\n* No consent from the family or person\n* Having had a stroke before\n* Severe hearing or vision loss\n* Individuals are excluded if they have other primary medical conditions that may affect language and motor functions (e.g. brain tumor, Parkinson's disease, severe post-stroke depression, Alzheimer's disease) or have undergone surgery.",{"count":54,"type":21},101,"OBSERVATIONAL","A large number of people have a stroke each year and it is a major cause of disability worldwide. Upper limb motor impairments, aphasia, body control problems and decreased motor imagery ability are common after stroke. Although there are studies showing that these impairments may be related to each other, there is no comprehensive study examining the relationship between Turkish language skills and these motor functions. The aim of this study was to evaluate the relationship between Turkish language skills and upper extremity motor function, trunk control and motor imagery ability in stroke patients.",[58,59,60,29,61,62],"Hemiplegia","Aphasia","Stroke","Upper Limbs","Motor Imagery","2025-04-19",{"date":65,"type":37},"2025-04-27",{"date":67,"type":37},"2024-12-10",{"date":69,"type":21},"2025-12-10",{"name":71,"class":44},"Izmir Bakircay University",{"id":73,"slug":74,"hasResults":11,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":4,"eligibilityCriteria":78,"healthyVolunteers":11,"sex":17,"minAge":79,"maxAge":18,"enrollmentInfo":80,"targetDuration":4,"studyType":22,"phases":82,"briefSummary":84,"conditions":85,"keywords":89,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":91,"lastUpdatePostDateStruct":92,"startDateStruct":94,"completionDateStruct":96,"leadSponsor":98,"locationsCount":5},"100576112","effects-of-trunk-focused-rehabilitation-on-spinal-mobility-trunk-control-and-hand-functions-in-cerebral-palsy-100576112","NCT06781047","Effects of Trunk-Focused Rehabilitation on Spinal Mobility, Trunk Control, and Hand Functions in Cerebral Palsy","Serebral Palsili Adölesanlarda Gövde Odaklı Rehabilitasyonun Spinal Mobilite, Gövde Kontrolü ve El Fonksiyonları Üzerine Etkilerinin İncelenmesi","Inclusion Criteria:\n\n1. Levels 1 and 2 according to Gross Motor Function Classification System (GMFCS)\n2. Viking Speech Scale Turkish version\u002F(VSS-T) 1-2 level, understood to speak and able to take commands\n3. Adolescents with CP between the ages of 12-18\n4. Those whose guardian \u002F legal representative and themselves have received an Informed Voluntary Consent Form\n5. No hip dislocation\n6. Scoliosis below 25 degrees according to the radiographic evaluation made in the last 6 months\n\nExclusion Criteria:\n\n1. Having had any surgery related to the intrathecal baclofen pump\n2. Having botulinum toxin injection treatment or orthopedic surgery within the last 6 months\n3. Having severe vision, hearing, and cognitive deficiencies\n4. Acute medical illness","12 Years",{"count":81,"type":21},40,[83],"NA","Main Purpose: This study aims to investigate the effects of trunk-focused rehabilitation on trunk control, spinal mobility, and manual skills in adolescents with cerebral palsy (CP).\n\nSecondary Purpose: To investigate its effects on functional health.",[86,87,29,88],"Cerebral Palsy (CP)","Adolescent","Exercise",[90],"cerebral palsy, trunk training, trunk control exercise","2025-02-04",{"date":93,"type":37},"2025-02-07",{"date":95,"type":37},"2024-05-15",{"date":97,"type":21},"2025-06-25",{"name":99,"class":44},"Saglik Bilimleri Universitesi"]